(Q34774464)

4 August 2017

1 reference

title

Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting (English)

1 reference

4 August 2017

Kathleen Mulligan

1

1 reference

4 August 2017

Morris Schambelan

series ordinal

2

1 reference

4 August 2017

publication date

1 September 2002

1 reference

International Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

85

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

151-159

1 reference

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Changes in the mix of AIDS-defining conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Body composition studies in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Longitudinal changes in body composition measured with a variety of methods in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Cross-sectional and longitudinal evaluation of body composition in men with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Energy expenditure and wasting in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Megestrol acetate in patients with AIDS-related cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Megestrol acetate in patients with AIDS and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Use of human growth hormone combined with nutritional support in a critical care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Endocrine disorders in men infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

A trial of testosterone therapy for HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Oxandrolone in AIDS-wasting myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900247-4

7 January 2021

10.1016/S0167-5273(02)00247-4

Identifiers

DOI

1 reference

4 August 2017

1 reference